Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its ...

Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...

UC Davis researchers engineered wheat that encourages soil bacteria to convert atmospheric nitrogen into plant-usable ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is among the top 10 stocks to buy from Cathie Wood’s stock portfolio. CRISPR made up ...

Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...

America's next wave of scientific talent may come from Lambert High School, where students used CRISPR to develop a promising ...